meaningful use: past, present and future · meaningful use is using certified electronic health...
TRANSCRIPT
1
Click to edit Master title style
8/24/2016 1
Meaningful Use: Past, Present and Future
Bruce Maki, MAM-CEITA / Altarum Institute
Regulatory Analyst and Project Manager
2
Agenda
▲Overview of M-CEITA
▲Meaningful Use
– Where have we been?
– Where are we now?
– Where are we headed?
▲Questions and Answers
3
Who is M-CEITA?
▲ Michigan Center for Effective Information Technology Adoption (M-CEITA)
▲ One of 62 ONC Regional Extension Centers (REC) originally funded to provide education & technical assistance to primary care providers across the country
▲ Founded as part of the HITECH Act to accelerate the adoption, implementation, and effective use of electronic health records (EHR), e.g. 90-days of MU
▲ Originally Funded by ARRA of 2009 (Stimulus Plan)
▲ Purpose: support the Triple Aim by achieving 5 overall performance goals
Meaningful Use
Improve
Quality, Safety &
Efficiency
Performance Measurement
Certified Technology Infrastructure
Engage
Patients &
Families
ImproveCare
Coordi-nation
ImprovePopulation
AndPublicHealth
EnsurePrivacy
AndSecurity
Protections
Improve patient experience
Improve population health
Reduce costs3THE TRIPLE AIM
4
Meaningful Use Support
Security Risk Assessment
Targeted Process Optimization (Lean)
Audit Preparation
M-CEITA Services
Technical assistance, including workflow redesign, security risk assessment and MU compliance. (e.g. patient portal and clinical quality measures)
Support meeting the requirements of MU Measure: Protect Electronic Health Information, including an assessment using our exclusive tool.
A workflow analysis and redesign of core processes using Lean principles to
increase efficiency and reduce duplication. (e.g. chart prep, document management, test tracking, revenue cycle, etc.)
A review of Meaningful Use attestation documentation using our exclusive Audit File Checklist to correct any issues before completing the process.
PQRS SupportTechnical Assistance for the Physician Quality Reporting System including measure selection as well as reporting method selection and assistance.
GLPTN - Great Lakes Practice Transformation NetworkNo cost Technical Assistance to eligible providers in support of quality
improvement initiatives, PQRS support, and preparing for upcoming advanced payment model changes under MACRA/MIPS.
5
The Past
A Brief History
of Meaningful Use
6
Healthcare’s Shifting Paradigm
Role Changing Paradigm
Healthcare Combating Illness Improving Wellness
Physicians Directors of Care Collaborators in Care
Patients Passive Recipients Active Participants
HealthInformation
Siloed and Episodic Integrated and Longitudinal
Health IT Supporting Tasks Enhancing Understanding
This paradigm shift requires significant investments, innovative people and extensible tools.
7
HIT & HIE
HITECH Act: Transformation CatalystHealth Information Technology for Economic and Clinical Health Act
HITECH Act
Pre 2009 2009 2014
A system plagued by inefficiencies
Paper Records
EHR Incentive Programs and 62 Regional Extension
Centers (RECs)
Widespread adoption and meaningful use of HIT
8
Meaningful Use…as defined by CMS
▲ Meaningful Use is using certified electronic health record (EHR) technology to:
– Improve quality, safety, efficiency, and reduce health disparities
– Engage patients and families
– Improve care coordination and population and public health
– Maintain privacy and security of patient health information
▲ Ultimately, it is hoped that Meaningful Use compliance will result in:
– Better clinical outcomes
– Improved population health outcomes
– Increased transparency and efficiency
– Empowered individuals
– More robust research data on health systems
9
Stage 1
Data capture and sharing
Stage 2
Advanced clinical processes
Stage 3
Improved outcomes
Meaningful Use: A path to better outcomes and quality
For more information on meaningful use of EHRs, visit: http://www.cms.gov/EHRIncentivePrograms/35_Meaningful_Use.asp
Better clinical outcomes Improved population health outcomes Increased transparency and efficiency Empowered individuals More robust research data on health
systems
10
15 C
ore
Meas
ure
s (
EPs
mu
st m
eet
all)
1 CPOE for medications (entered into the electronic record) 30%
2 Drug-drug and drug-allergy interaction checks (enable only) YES
3 Problem list of current & active diagnoses 80%
4 E-Prescribing (transmission to pharmacy) 40%
5 Active medication list 80%
6 Active medication allergy list 80%
7 Demographics recorded as structured data 50%
8 Record/chart changes in vitals (height, weight and blood pressure, etc.) 50%
9 Record smoking status as structured data, 13+ years old 50%
10 Clinical Quality Measures (CQM) YES
11 Implement (1) clinical decision support rule YES
12 Electronic copy of patient health information, upon request w/in 3 days 50%
13 Clinical Summaries, within 3 business days 50%
14 Electronic exchange of key clinical information among providers of care YES
15 Protect electronic health information (SRA) YES
2013 MU Stage 1 – Summary of Measures
11
10 Menu Measures (EPs must meet 5 of 10)
1 Drug Formulary Checks – implemented (enable only) YES
2 Clinical lab test results (as structured data) 40%
3 Patient lists (by specific condition) YES
4 Patient reminders (65+ years, and < 5 years) 20%
5 Patient electronic access (patient portal) 10%
6 Patient-specific education resources 10%
7 Medication reconciliation 50%
8 Transition of care summary 50%
9 Immunization registries data submission YES
10 Syndromic Surveillance data submission YES
*Public health objective: At least one public health objective must be selected.
2013 MU Stage 1 – Summary of Measures
12
The Present
Modified Stage 2
13
▲Released: October 6, 2015
▲Published: October 16, 2015
▲Effective: December 15, 2015
Medicare and Medicaid Programs; Electronic Health Record Incentive Program—Stage 3 and Modifications
to Meaningful Use in 2015 Through 2017 Final Rule with Comment Period
(aka Modified Stage 2 / Stage 3 Final Rule)
14
Key changes in the Modified Stage 2 Rule
▲ Stage 1 and Stage 2 objectives and measures restructured to align with Stage 3
▲ Streamlined the program by removing redundant, duplicative, and topped out (RDT) measures
▲ One set of objectives and measures for all participants
▲ Patient engagement objectives that require “patient action” were modified
▲ Limited accommodations for “Scheduled” Stage 1 EPs in 2016 (CPOE)
▲ Significant changes to the Public Health objective
▲ Optional “Alternate Exclusions” added to Public Health (2015-2016)
– No proof of intent/documentation required to claim Alt Exclusions
15
Meaningful Use Reporting Periods
▲ 2016
– New Participants: Any continuous 90 days within the Calendar Year (CY)
– Returning Participants: Full Calendar Year (366 days)
NPRM (notice of proposed rule making) will likely reduce this to 90 days. Final Rule due by Nov 1
▲ 2017
– New Participants: Any continuous 90 days within the CY
– Providers electing Stage 3: Any continuous 90 days within the CY (requires 2015 CEHRT)
– Returning Participants: Full Calendar Year (365 days)
16
Measures removed under Modified Stage 2 (…but “Still Meaningful”)
17
“Modified Stage 2” Meaningful Use Objectives:
1. Protect Patient Health Information (SRA)
Not Episodic, should cover entire program year
Conduct within same CY as reporting period, acceptable to be conducted outside of reporting period if reporting period is < CY but must be conducted prior to attestation
2. Clinical Decision Support (CDS) (2 measures)
Implement CDS Interventions
Implement Interaction Checks
3. Computerized Provider Order Entry (CPOE) (3 measures)
Medication Orders
Laboratory Orders**
Radiology Orders**
** EPs scheduled to be in Stage 1 in 2016 are not required to report on Lab and Radiology orders, only Medication orders
18
4. Electronic Prescribing (eRx)
5. Health Information Exchange (formerly Summary of Care)
6. Patient Specific Education
7. Medication Reconciliation
8. Patient Electronic Access (VDT/Pt Portal) (2 measures)
Timely Access
Usage
9. Secure Electronic Messaging
10. Public Health Reporting (3 measures)
Immunization Registry
Syndromic Surveillance Registry
Specialized Registry
“Modified Stage 2” MU Objectives (cont’d):
19
Meaningful Use Progression for EPs
2011 -2013
20142015 -2017
2018
Stage 1
15 Core
5 Menu
6 CQMs
Stage 1
13 Core
5 Menu
9 CQMs
Stage 2
17 Core
3 Menu
9 CQMs
Modified Stage 2
10 Objectives
9 CQMs
Stage 3
Optional: 2017
8 Objectives,
some with
lowered
thresholds
Stage 3
8 Objectives
CQM reporting
is required by
regulations;
Medicare
rulemaking to
address
reporting
requirements
20
The Future
STAGE 3 or MACRA/MIPS/APM
…or both!
21
Meaningful Use Stage 3
Modified Stage 2 Crosswalk to Stage 3
Objectives Modified Stage 2 Stage 3 (2018)*
SRAConduct or Review during CY and prior to attestation including
addressing encryption/security of data created or maintained in CEHRT
CPOE
Medications > 60% > 60%
Labs > 30% > 60%
Radiology > 30% > 60%
eRx
> 50% of all permissible prescriptions are queried for a
drug formulary AND transmitted electronically
> 60% of all permissible prescriptions are queried for a drug
formulary AND transmitted electronically
Clinical Decision Support
Rules 5 Enabled for Entire Reporting Period (RP)
Interactions Enabled for Entire Reporting Period (RP)
22
Meaningful Use Stage 3 (cont’d)
Objectives Modified Stage 2 Stage 3 (2018)*
Patient Education > 10% Incorporated into Patient Electronic Access
View, Download
and Transmit
(VDT)
Access > 50% w/in 4 days Incorporated into Patient Electronic Access
Usage > 5%Incorporated into Coordination of Care through
Patient Engagement
Patient Electronic
Access
Access
N/A
> 80% of all unique patients are provided timely access to VDT their health information AND
ensure health information is available for the patient to access using any application of their choice that is configured to meet the technical
specifications of the API in the EPs CEHRT
Patient Education
For > 35% of unique patients, CEHRT is used to identify educational resources to which electronic
access is provided
Secure Messaging > 5%Incorporated into Coordination of Care through
Patient Engagement
23
Meaningful Use Stage 3 (cont’d)
Objectives Modified Stage 2 Stage 3 (2018)*
Coordination of Care through
Patient Engagement
VDT
N/A
> 10% of unique patients engage with EHR by either 1) VDT health information or 2) access health information via an API or 3) a combination of
both
Secure Messaging> 25% of unique patients, or
in response to a secure message sent by patient
Patient Generated Health Data
> 5% of unique patients incorporate non-clinical
setting data into the CEHRT
Medication Reconciliation > 50%Incorporated into Health
Information Exchange
24
Meaningful Use Stage 3 (cont’d)
Objectives Modified Stage 2 Stage 3 (2018)*
Health Information
Exchange
Provide SoC Electronically
Use CEHRT to create a SoC AND transmit electronically for
> 10% of ToCs
Use CEHRT to create a SoC AND transmit electronically for > 50% of ToCs
Receive or Retrieve SoC
N/A
EP receives or retrieves a SoC for > 40% of ToCs in which the EP has never encountered
the patient AND incorporates it into the patient’s CEHRT record
Reconciliation of Clinical
InformationN/A
Perform a reconciliation of clinical information for > 80% of transitions/referrals or for patient
encounters in which the EP has never encountered the patient
25
Meaningful Use Stage 3 (cont’d)
Objectives Modified Stage 2 Stage 3 (2018)*
Public Health
Imms Registry
Actively Engaged w/2 of 3
Actively Engaged w/3 of 5
Syndromic Surveillance
Specialized Registry
Electronic Case Reporting N/A
PH Registry ReportingIncluded as Specialized
RegistryClinical Data Registry Reporting
* As Stage 3 is optional in 2017, some measure thresholds have been reduced to allow early adopters ease in transitioning to the 2018 Stage 3 required thresholds
26
MACRA:
Paying for Value and Quality
27
MACRA: What is it?
▲ Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). [AKA “Doc Fix” bill]
▲ Bipartisan legislation (yes, really) that replaced the flawed Sustainable Growth Rate (SGR) formula by paying clinicians for the value and quality of care they provide
▲ MACRA is more predictable than SGR. It will increase the number of physicians participating in alternative payment models, with those in high quality, efficient practices benefiting financially
▲ Extends funding for Children’s Health Insurance Program (CHIP) for two years
▲ MANY of the details have yet to be determined, and there were several areas where feedback was sought from the health care community
▲ And introduces…
28
Clinicians who receive a substantial
portion of their revenues (at least 25% of
Medicare revenue in 2018-2019 and
threshold will increase over time)
from qualifying alternative payment
mechanisms will not be subject to MIPS.
Incentives: They will receive a 5% bonus
each year from 2019 to 2024 (based on
aggregate payments from Medicare for
the preceding year).
Payment rates in 2019 will be maintainedthrough 2025 but with + / - adjustmentsbased on the composite performancescore of each eligible physician or otherhealth professional on a 0-100 point scalebased on four performance measures(more to come on the measures).
Incentives: More to come on that too…
Merit-based Incentive Payment System
(MIPS)
Alternative Payment Model
(APM)
Two Paths to Payment Reform
29
Part of a broader push towards VALUE and QUALITY
The Quality Payment Program
30
CMS Framework for Alternative Payment Models (APMs)
31
MACRA’s Long-term Aim
Note:
• Size of “bubble” indicates overall investment in each category of APM
• Over time, APMs will move up the Y-axis and there will be more investment in the higher
categories
*Source: CPR 2014 National Scorecard on Payment Reform, based on the National commercial market using 2013 data.
32
Path 1: Merit-Based Incentive Payment System
▲ Combines multiple Medicare Part B quality reporting programs into a single program
▲ This new, single program is based on:
– Quality (PQRS/VM-Quality Program)
– Resource Use (Cost) (VM-Cost Program)
– Advancing Care Information (Medicare MU)
– Clinical Practice Improvement (new category)
What is MIPS?
*MACRA does not alter or end the Medicaid EHR Incentive Program
33
Merit-Based Incentive Payment System
▲ MIPS payment adjustments based on Composite Performance Score (CPS) increasing from +/- 4% in 2019 to +/- 9% in 2022 and later*
▲ Budget neutral unless an exception applies
▲ Additional funding for positive adjustments for exceptional performance (2019 – 2024)
▲ Incentive payments for certain eligible clinicians (ECs) who participate in Alternative Payment Models (APMs)
▲ Higher update rate for “qualifying APM participants” (QPs) beginning in 2026
*Note: The upward adjustment may differ somewhat since it is scaled to achieve budget neutrality
34
MIPS Performance Categories
A MIPS Composite Score (CPS) will be calculated based on the performance of 4 weighted categories:
▲ Resource Use – 10%
▲ Clinical Practice Improvement Activities – 15%
▲ Advancing Care Information – 25%
▲ Quality – 50%
35
Advancing Care Information
Objective Measure
Protect Patient Health Information Security Risk Analysis
Electronic Prescribing ePrescribing
Patient Access
Patient-Specific Education
View, Download and Transmit (VDT)
Secure Messaging
Patient-Generated Health Data
Exchange Information with Other Physicians or Clinicians
Exchange Information with Patients
Clinical Information Reconciliation
Immunization Registry Reporting
(Optional) Syndromic Surveillance Reporting
(Optional) Electronic Case Reporting
(Optional) Public Health Registry Reporting
(Optional) Clinical Data Registry Reporting
MIPS Advancing Care Information Objectives and Measures
Patient Electronic Access
Coordination of Care Through Patient Engagement
Health Information Exchange
Public Health and Clinical Data Registry Reporting
36
MIPS Composite Performance Score:
▲ Weights may be adjusted if there are not sufficient measures and
activities applicable for each provider type, including assigning a
scoring weight of “0” for a performance category
▲ ACI (aka MU) weighting can be decreased and shifted to other
categories if Secretary estimates the proportion of physicians who
are meaningful EHR users is 75% or greater (statutory floor for ACI weight is 15%)
▲ Performance threshold will be established based on the mean or
median of the composite performance scores during a prior period (Yrs 1 and 2 HHS Secretary will establish threshold)
▲ Those who score below the threshold will see negative payment
adjustments, those who score above it will see positive adjustments
37
MIPS - Incentives and Penalties
▲ Adjustments applied 2 years after performance year (e.g. 2019 payment adjustment is based on 2017 performance year)
▲ Performance threshold is mean or median of the composite score for all MIPS providers (except in first 2 years where Secretary will set)
▲ Linear payment adjustment based on composite score, as compared to performance threshold (may be +, - or =)
▲ If you score in the lowest quartile of providers, you will automatically be adjusted down to the maximum penalty
▲ Higher scores receive proportionally larger incentive payments, up to three times the maximum positive adjustment for the year (4% x 3 = 12% in 2019)
▲ Highest performers are eligible for an “exceptional performance bonus”
– Additional payment adjustment of +10% for MIPS providers exceeding the 25th
percentile of all MIPS scores above the performance threshold (through 2024)
Payment Adjustments
38
MIPS Incentive Payment Formula
*MACRA allows potential 3x upward adjustment which will be used to maintain budget neutrality
MIPS – Incentives and Penalties
39
The other fork in
the path to
Quality
Payments
Alternative Payment Models
40
Alternative Payment Models (APMs)What are they?
▲ Alternative Payment Model or APM is a generic term describing a payment model in which providers take responsibility for cost and quality performance and receive payments to support the services and activities designed to achieve high value
▲ According to MACRA, APMs include:
– Medicare Shared Savings Program (MSSP) ACOs
– Demonstrations under the Health Care Quality Demonstration Program
– CMS Innovation Center Models
– Demonstrations required by Federal Law (i.e. door is open for others to form)
▲ MACRA does not change how any particular APM pays for medical care and rewards value
▲ APM participants may receive favorable scoring under certain MIPS performance categories
▲ Only some of these APMs are “Advanced APMs”
41
▲ Advanced APMs offer greater potential inherent risks and rewards than MIPS
▲ Under MACRA, qualifying APM participants in “eligible” APMs:
− Are exempt from MIPS− Receive annual 5% lump sum bonus payments from 2019-2024− Receive a higher fee schedule update for 2026 and onward (.25% or .75%)
ADVANCED APMs
42
Proposed Financial Risk Criterion Narrows Current Options
43
Volume Thresholds for Advanced APMs
▲ A “qualifying APM” is one that meets increasing thresholds for the percentage of charges that pass through the APMs methodology
▲ An individual Eligible Clinician (EC) in a qualifying APM is a “Qualified APM Participant” or “QP”
▲ QP status is awarded to all advanced APM participants collectively (or to none as the case may be)
What if the threshold for QP status is not met?
▲ If ECs advanced APM does not meet the volume threshold to qualify it’s members for QP status, members are considered “Partially Qualifying”
▲ If an individual EC chooses to stay in the APM track, s/he will not receive the 5% bonus, but also will not be subject to MIPS
▲ If EC chooses, s/he can report MIPS measures and participate in the MIPS incentive track
44
Note: At first, most clinicians will be subject to MIPS
45
What path do I take in the Quality Payment Program?
46
TIMELINE
47
Resources
Modified Stage 2 Final Rule: http://federalregister.gov/a/2015-25595
MIPS/APM Proposed Rule: https://s3.amazonaws.com/public-
inspection.federalregister.gov/2016-10032.pdf
2016 Tipsheet: https://www.cms.gov/Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/Downloads/2016_EP
WhatYouNeedtoKnowfor2016.pdf
Modified Stage 2 Tipsheet: https://www.cms.gov/Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/Downloads/Stage3Ov
erview2015_2017.pdf
2016 Program Requirements and Tools
https://www.cms.gov/Regulations-and-
Guidance/Legislation/EHRIncentivePrograms/2016ProgramRequire
ments.html